Cargando…
Treatment of Breast Cancer-Related Lymphedema With Topical Tacrolimus: A Prospective, Open-Label, Single-Arm, Phase II Pilot Trial
PURPOSE: Breast cancer-related lymphedema (BCRL) is a chronic, progressive side effect of breast cancer treatment, occurring in one-third of patients treated with axillary lymph node dissection and nodal radiotherapy. Cluster of differentiation 4-positive (CD4(+)) cells plays a key role in BCRL by f...
Autores principales: | Gulmark Hansen, Frederik C., Jørgensen, Mads Gustaf, Sørensen, Jens Ahm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981991/ https://www.ncbi.nlm.nih.gov/pubmed/36762782 http://dx.doi.org/10.4048/jbc.2023.26.e2 |
Ejemplares similares
-
Prospective Validation of Indocyanine Green Lymphangiography Staging of Breast Cancer-Related Lymphedema
por: Jørgensen, Mads Gustaf, et al.
Publicado: (2021) -
Adipose‐derived regenerative cells and lipotransfer in alleviating breast cancer‐related lymphedema: An open‐label phase I trial with 4 years of follow‐up
por: Jørgensen, Mads Gustaf, et al.
Publicado: (2021) -
Indocyanine green lymphangiography is superior to clinical staging in breast cancer-related lymphedema
por: Jørgensen, Mads Gustaf, et al.
Publicado: (2021) -
Topical tacrolimus for the treatment of secondary lymphedema
por: Gardenier, Jason C., et al.
Publicado: (2017) -
Abstract 1: Topical Tacrolimus for the Treatment of Lymphedema
por: Gardenier, Jason C., et al.
Publicado: (2017)